Compare

Neuraxis, Inc vs Nuwellis, Inc. vs Escalon Medical Corp vs CapsoVision, Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNeuraxis, Inc
NRXS
Nuwellis, Inc.
NUWE
Escalon Medical Corp
ESMC
CapsoVision, Inc
CV
Year ended2025-12-312025-12-312026-06-302025-12-31
Revenue$3.57M$8.27M$12.74M$13.55M
Revenue growth (YoY)+32.9%-5.4%+5.7%+15.3%
Gross margin84.2%62.0%43.7% (computed)52.9%
Operating margin-219.4%-134.3%0.4%-188.3%
Net margin-218.5%-211.9%31.5%-186.8%
Net income-$7.80M-$17.52M$4.01M-$25.32M
EPS (Diluted)-$0.95-$25.39$0.27-$1.03
Operating cash flow-$6.43M-$10.81M-$402.6K-$22.86M
Free cash flow-$6.46M-$10.90M-$407.0K-$22.95M
Cash & equivalents$4.97M$1.08M$3.07Mn/a
Total assets$6.40M$6.12M$9.13M$18.16M
Total liabilities$3.00M$3.49M$3.20M$4.90M
Shareholders' equity$3.40M$2.62M$5.93M$13.26M
Return on year-end equity-229.5%-667.7%67.7%-190.9%
Shares outstanding10.65M1.69M7.42M46.87M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNeuraxis, IncNuwellis, Inc.Escalon Medical CorpCapsoVision, Inc
Latest$3.57M
Ended 2025-12-31
$8.27M
Ended 2025-12-31
$12.74M
Ended 2026-06-30
$13.55M
Ended 2025-12-31
1 year earlier$2.69M
Ended 2024-12-31
$8.74M
Ended 2024-12-31
$12.05M
Ended 2025-06-30
$11.76M
Ended 2024-12-31
2 years earlier$2.46M
Ended 2023-12-31
$8.86M
Ended 2023-12-31
$11.98M
Ended 2024-06-30
n/a
3 years earlier$2.68M
Ended 2022-12-31
$8.54M
Ended 2022-12-31
$12.18M
Ended 2023-06-30
n/a
4 years earliern/a$7.92M
Ended 2021-12-31
$10.70M
Ended 2022-06-30
n/a